This website or its third-party tools process personal data. You can opt out of the sale of your personal information by clicking on the “Do Not Sell or Share My Personal Information” link.
Powered by
Opt-out Preferences
We use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. However, you can opt out of these cookies by checking "Do Not Sell or Share My Personal Information" and clicking the "Save My Preferences" button. Once you opt out, you can opt in again at any time by unchecking "Do Not Sell or Share My Personal Information" and clicking the "Save My Preferences" button.
QLOSI is a prescription ophthalmic solution for presbyopia, offering improved near vision without reading glasses; uniquely formulated for fast, temporary vision enhancement.
QLOSI, an ophthalmic cholinergic agonist solution, has mild side effects, manageable interactions, low misuse risk, simple dosing, and minimal monitoring needs, with minor considerations for special populations and potential long-term tolerance, aligning well with FDA ACNU safety and usability guidelines.
ACNU Feasibility Scorecard
Chart with 11 data points.
QLOSI
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying ← Lower is Better!. Data ranges from 1 to 3.
Safety & Risk ProfileSeverity of Side EffectsOverdose PotentialRisk of MisuseDrug-Drug InteractionsSpecial ConsiderationsUsability DifficultyDosing ComplexityMonitoring RequirementsAdherence DifficultyPotential for Tolerance